StockData

Astera Labs vs Synaptics

ALAB and SYNA side by side, both in electronic components and accessories. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ALAB and SYNA compare

Astera Labs is the larger company, worth 9.7 times as much as Synaptics ($44.9B against $4.6B).

Astera Labs grew revenue faster over the last twelve months (98.5% versus 11.4% for Synaptics).

Astera Labs keeps more of each dollar of sales as profit, with a net margin of 30.7% compared with −41.0% at Synaptics.

Astera Labs scores higher on the StockData Score (12 against 3 for Synaptics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricALABSYNA
Size and price
Market cap$44.9B$4.6B
Share price$258.70$117.86
Change, 1 year49.0%68.3%
Change, 5 years–−52.7%
Beta (5Y)2.832.00
Employees7561,700
StockData Score
Total score12 (better)3
Valuation score00
Growth score2 (better)1
Performance score4 (better)0
Health score6 (better)2
Dividend score00
Valuation
P/E128×–
P/S37.3×3.8× (better)
P/B26.0×5.0× (better)
EV/EBITDA153×–
P/FCF162×45.5× (better)
FCF yield0.62%2.2% (better)
Fair value$58.59$98.41
Margin of safety−342%−19.8% (better)
Growth
Revenue growth (TTM)98.5% (better)11.4%
Revenue growth, 5Y average–−2.2%
Net income growth (TTM)269%–
Profitability
Gross margin75.1% (better)44.7%
Operating margin22.8% (better)−5.6%
Net margin30.7% (better)−41.0%
FCF margin23.0% (better)8.5%
Return on equity25.8% (better)−42.2%
Return on invested capital101% (better)−3.4%
Financial health
Debt / equity0.000.90 (better)
Current ratio10.05 (better)1.12
Altman Z-score133.04 (better)3.34
Piotroski F-score56 (better)
Dividends and buybacks
Buyback yield–2.0%
Shareholder yield0.00%2.0% (better)
Ownership
Held by institutions73.6%107%
Held by insiders11.4%3.1%
Insider net buying, 12 months−$779M−$8.2M (better)
Superinvestors holding1–
Short interest, % of float6.0%7.3%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.